{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:59:52Z","timestamp":1783385992764,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ajg.2015.09.001","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T20:44:45Z","timestamp":1447533885000},"page":"99-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Essential phospholipids as a supportive adjunct in the management of patients with NAFLD"],"prefix":"10.1016","volume":"16","author":[{"given":"Asad Izziddin Mustafa","family":"Dajani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan M.","family":"Abu Hammour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen R.","family":"Al Jaberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Nounou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Ilah M.","family":"Semrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2015.09.001_b0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/cs0650645","article-title":"Biochemical analysis of hepatic lipid in alcoholic and diabetic and control subjects","volume":"65","author":"Cairns","year":"1983","journal-title":"Clin Sci"},{"key":"10.1016\/j.ajg.2015.09.001_b0010","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","article-title":"GI epidemiology: nonalcoholic fatty liver disease","volume":"25","author":"Angulo","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2015.09.001_b0015","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2015.09.001_b0020","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1111\/j.1572-0241.2000.03293.x","article-title":"An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities","volume":"95","author":"Sorbi","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.ajg.2015.09.001_b0025","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.bbadis.2011.07.017","article-title":"Genetic modifiers of non-alcoholic fatty liver disease progression","volume":"1812","author":"Anstee","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajg.2015.09.001_b0030","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/j.1572-0241.2001.04667.x","article-title":"Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency and severity of disease","volume":"96","author":"Willner","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajg.2015.09.001_b0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9343(99)00315-0","article-title":"Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds","volume":"108","author":"Struben","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.ajg.2015.09.001_b0040","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/j.1572-0241.2001.04667.x","article-title":"Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease","volume":"96","author":"Willner","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajg.2015.09.001_b0045","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2015.09.001_b0050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","article-title":"Noninvasive evaluation of NAFLD","volume":"10","author":"Castera","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2015.09.001_b0055","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"NAFLD as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajg.2015.09.001_b0060","doi-asserted-by":"crossref","first-page":"g4596","DOI":"10.1136\/bmj.g4596","article-title":"Clinical review, nonalcoholic fatty liver disease","volume":"349","author":"Sattar","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajg.2015.09.001_b0065","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.ajg.2015.09.001_b0070","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.ajg.2015.09.001_b0075","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Non-alcoholic fatty liver disease: the mist gradually clears","volume":"48","author":"de Alwis","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2015.09.001_b0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCA.0b013e3282583c0d","article-title":"Association between nonalcoholic fatty liver disease and coronary artery disease","volume":"18","author":"Arslan","year":"2007","journal-title":"Coronary Artery Dis"},{"key":"10.1016\/j.ajg.2015.09.001_b0085","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","article-title":"The natural history of nonalcoholic fatty liver disease: a clinical histopathological study","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2015.09.001_b0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3748\/wjg.v12.i3.345","article-title":"NAFLD and the metabolic syndrome","volume":"12","author":"Gill","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajg.2015.09.001_b0095","first-page":"243","article-title":"A study of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus in a tertiary care centre","volume":"6","author":"Jayarama","year":"2012","journal-title":"South India J Clin Diagn Res"},{"key":"10.1016\/j.ajg.2015.09.001_b0100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ajg.2015.09.001_b0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/bega.2002.0330","article-title":"Other disease associations with non-alcoholic fatty liver disease (NAFLD)","volume":"16","author":"Allard","year":"2002","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.ajg.2015.09.001_b0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2008-1027157","article-title":"Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients","volume":"46","author":"Lobstein","year":"2008","journal-title":"Z Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2015.09.001_b0115","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/MCB.26.3.1063-1076.2006","article-title":"Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein","volume":"26","author":"Hung","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.ajg.2015.09.001_b0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2036.2008.03752.x","article-title":"Review article: diagnosis and treatment of non-alcoholic fatty liver disease","volume":"28","author":"Oh","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2015.09.001_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.1840150303","article-title":"Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes","volume":"15","author":"Li","year":"1991","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajg.2015.09.001_b0130","first-page":"148","article-title":"Cell membranes, endothelia, and atherosclerosis\u2014the importance of dietary fatty acid balance","volume":"1","author":"Kidd","year":"1996","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.ajg.2015.09.001_b0135","first-page":"517","article-title":"Controlled study using multiply-unsaturated phosphatidyl-choline in comparison with placebo in the case of alcoholic liver steatosis","volume":"72","author":"Schuller Perez","year":"1985","journal-title":"Med Welt"},{"key":"10.1016\/j.ajg.2015.09.001_b0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(01)06042-1","article-title":"Metformin in nonalcoholic steatohepatitis","volume":"358","author":"Marchesini","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajg.2015.09.001_b0145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2004.01888.x","article-title":"Metformin in the treatment of patients with nonalcoholic steatohepatitis","volume":"19","author":"Uygun","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2015.09.001_b0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.2004.02025.x","article-title":"Metformin in the treatment of nonalcoholic steatohepatitis: a pilot open label trial","volume":"20","author":"Nair","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ajg.2015.09.001_b0155","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/S1542-3565(03)00198-8","article-title":"Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity","volume":"1","author":"Shadid","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2015.09.001_b0160","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/290734","article-title":"The effects of pioglitazone on biochemical markers of bone turnover in the patients with type 2 diabetes","volume":"2013","author":"Xiao","year":"2013","journal-title":"Int J Endocrinol"},{"issue":"6","key":"10.1016\/j.ajg.2015.09.001_b0165","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2036.2010.04405.x","article-title":"Pioglitazone in the treatment of NASH: the role of adiponectin","volume":"32","author":"Castaldelli","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ajg.2015.09.001_b0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrah","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.ajg.2015.09.001_b0175","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/hep.22402","article-title":"Statins in liver disease: a molehill, an iceberg, or neither?","volume":"48","author":"Argo","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajg.2015.09.001_b0180","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11883-012-0305-5","article-title":"Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review","volume":"15","author":"Nseir","year":"2013","journal-title":"Curr Atherosclerosis Rep"},{"issue":"2","key":"10.1016\/j.ajg.2015.09.001_b0185","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/hep.24461","article-title":"Hepatic triglyceride content in individuals with reduced intestinal cholesterol absorption due to variants in NPC1L1","volume":"54","author":"Ramirez","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ajg.2015.09.001_b0190","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2005.08.021","article-title":"Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients","volume":"184","author":"Antonopoulos","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajg.2015.09.001_b0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1758-5996-5-32","article-title":"Pleiotropic effects of Rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl\/6 mice","volume":"5","author":"Neto-Ferreira","year":"2013","journal-title":"Diabetol Metab Syndrome"},{"issue":"2","key":"10.1016\/j.ajg.2015.09.001_b0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Sumida","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajg.2015.09.001_b0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alcohol.2004.07.008","article-title":"Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis","volume":"34","author":"Lieber","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.ajg.2015.09.001_b0210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11894-004-0027-0","article-title":"New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments","volume":"6","author":"Lieber","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.ajg.2015.09.001_b0215","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MOL.0b013e3282ffaf96","article-title":"Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease","volume":"19","author":"Cohn","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajg.2015.09.001_b0220","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ps\/76.5.689","article-title":"Dietary safflower phospholipid reduces liver lipids in laying hens","volume":"76","author":"An","year":"1997","journal-title":"Poultr Sci"},{"key":"10.1016\/j.ajg.2015.09.001_b0225","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/S0024-3205(00)00840-7","article-title":"Dietary polyenylphosphatidylcholine decreases cholesterolemia in hypercholesterolemic rabbits: role of the hepato-biliary axis","volume":"67","author":"Polichetti","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.ajg.2015.09.001_b0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0955-2863(02)00253-X","article-title":"Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats","volume":"14","author":"LeBlanc","year":"2003","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.ajg.2015.09.001_b0235","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.nut.2004.11.019","article-title":"Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid","volume":"21","author":"Buang","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.ajg.2015.09.001_b0240","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1021\/jf071225x","article-title":"Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats","volume":"55","author":"Shirouchi","year":"2007","journal-title":"J Agric Food Chem"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197915000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197915000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T15:12:41Z","timestamp":1567350761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197915000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":48,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1687197915000763"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2015.09.001","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Essential phospholipids as a supportive adjunct in the management of patients with NAFLD","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2015.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Arab Journal of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}